Table 3 Preoperative Baseline Characteristics
Study | Mean Age | Male (%) | Diabetes (%) | Renal Failure (%) | A Fib (%) | LVEF (%) | Valve Related Failure (%) | Procedure Related Failure (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MVr | MVR | MVr | MVR | MVr | MVR | MVr | MVR | MVr | MVR | MVr | MVR | MVr | MVR | MVr | MVR | |
Nishida et al. [7] | 48.7 ± 2.8 | 62.9 ± 1.7 | 64 | – | – | – | – | 31 | – | – | 61 | 10 | 35 | 84 | ||
Zegdi (Late) et al. * [9] | 65 | 77 | – | – | 8 | 71 | – | – | – | – | ||||||
Zegdi et al. [11] | 55 | 66 | 71 | 77 | – | – | – | – | – | – | – | – | – | – | – | – |
Kwedar et al. * [12] | 74 | 51 | 22.7 | 12.2 | 68 | – | – | – | – | – | ||||||
Ma et al. [13] | 55 ± 15.7 | 62.6 ± 8.4 | 65 | 71 | 13 | 6 | – | – | – | – | 62.2 ± 4.5 | 59.7 ± 6.8 | – | – | – | – |
Kilic et al. [14] | 61 ± 16 | 62 ± 15 | 62 | 45 | 21 | 20 | 6 | 14 | – | – | – | – | 52.5 | 70.5 | 47.5 | 29.5 |
Suri et al. [15] | 64 ± 13 | 67 ± 11 | 77 | 65 | – | – | – | – | – | – | – | – | 44 | 69 | 56 | 31 |
Dumont et al. [16] | 57 ± 9.8 | 63 ± 12 | 73 | 57 | – | – | – | – | – | – | 12 | 31 | – | – | – | – |